The independent source for health policy research, polling, and news.
14,481 - 14,500 of 112,177 Results
The money will be used to train more medical students and reach out to people in rural and remote areas of Utah. The New York Times, meanwhile, tackles health care worker's garment and PPE fashion. Also, worries of shame culture swirl after a Mormon sex therapist's ouster.
The annual cost growth is above figures for the period 2017 to 2020, and will hit as people seek care they delayed during the pandemic. Meanwhile, UnitedHealthcare's plans to scrutinize and retroactively deny some emergency care claims cause controversy.
The Washington Post and Axios report on the ongoing fallout from the "contentious" decision to approve Aduhelm while CNN covers the costs and side-effects of the new drug. The Cincinnati Enquirer notes it will be available at UC Health and two other Ohio sites.
Those were two of the issues on which Democrats and Republicans on the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies from the two parties did not agree while considering the HHS spending plan for fiscal 2022.
The law would have banned abortions after eight weeks of pregnancy and also specified that abortions could not be performed solely on the fear that a fetus might have Down syndrome.
To increase vaccine incentives and availability, Medicare will now pay providers $75 per at-home vaccination -- almost double the previous $40 payment. Other Medicare news is on dental services and the big price tag of the newly approved Alzheimer's drug.
Molnupiravir is taken orally every 12 hours for five days; a course consists of 10 pills. The federal government will spend about $1.2 billion to buy 1.7 million courses of the drug, which has not been approved but shows promise for newly diagnosed, non-hospitalized covid patients.
Despite lower reported covid cases, the U.S. Surgeon General warns it's not time to "let your guard down." Dr. Anthony Fauci has also urged more Americans to get vaccinated in the light of the delta covid variant. Reports say hospitalizations are on the rise in some places.
"The problem with boosters is, we'll always be at least six months behind the curve," Dr. Jonathan Javitt, CEO of NRx pharmaceutical company and adjunct professor at Johns Hopkins School of Medicine, told Fox News.
Professor David Baltimore had been one of the most prominent figures driving the lab-escape theory for the source of covid. Meanwhile, Dr. Anthony Fauci calls out conspiracy theory-based attacks on him as "preposterous" and "painfully ridiculous."
Meanwhile, San Francisco has one of California’s highest rates of vaccination, with 72% of residents having received at least one dose.
The new mandatory workplace rules for health care settings are expected to be announced today, Politico reports. Unions had pushed the Biden administration to include more businesses. Separately, the White House tells government agencies that federal workers shouldn't "generally" require vaccines to work on-site.
Pfizer confirmed the deal for its shot -- sold at a not-for-profit price -- which President Joe Biden will announce during this week's G7 summit. It's expected that 200 million doses will be distributed this year through COVAX and 300 million next year.
Today's early morning highlights from the major news organizations.
Editorial pages discuss these various public health topics.
Opinion writers tackle these covid and vaccine issues.
Colorado lawmakers are now requiring private insurers to offer plans that cut costs. Meanwhile, Philly's "Naked Bike Ride" will this year require masks, and a blue-green algae bloom prompts a health alert in Orange County.
The United Nations issued a proclamation declaring the need for urgent action to end AIDS by 2030. In other news, the U.K. is sending military backup to hospitals stressed by covid surges, and E.U. lawmakers OK a type of digital vaccine passport for tourists.
Read recent commentaries about drug-cost issues.
An agency advisory committee recommended against the Food and Drug Administration approving Aduhelm, and one of its expert members has since resigned. More controversy about the drug's approval is reported in CNBC, Stat, Axios, The Baltimore Sun and Fox News.
© 2026 KFF